Physician profile
Eloy Ituarte
NPI 1982633194
$539.32
in general payments reported to CMS, 2019-2025
8 companies · $359 in 2025
The $359 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $135 · 2024: $45.57 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $539.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $135.23 | 2023 | Qutenza |
| Exact Sciences Corporation | $109.42 | 2025 | The Cologuard Plus Collection Kit |
| Corcept Therapeutics | $77.45 | 2025 | Korlym |
| Novo Nordisk INC | $52.33 | 2025 | Wegovy |
| Hologic Sales and Service, LLC | $48.99 | 2024-2025 | Aptima |
| Alkermes, INC. | $47.86 | 2025 | Vivitrol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.61 | 2025 | |
| Merck Sharp & Dohme LLC | $21.43 | 2024 | M-M-R II, Capvaxive, Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eloy Ituarte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.